Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer

BACKGROUND AND PURPOSE: For irradiation of localized prostate-cancer, moderately-hypofractionated regimens with a variety of dose per fraction are used. We adopted a regimen of 70 Gy in 28 fractions of 2.5 Gy, using state of the art radiotherapy (RT) and closely monitored the efficacy, toxicity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Houben, Jeroen, McColl, Gill, HAM Kaanders, Johannes, Smeenk, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170415/
https://www.ncbi.nlm.nih.gov/pubmed/34113724
http://dx.doi.org/10.1016/j.ctro.2021.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170415/
https://www.ncbi.nlm.nih.gov/pubmed/34113724
http://dx.doi.org/10.1016/j.ctro.2021.05.005

Ejemplares similares